Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton May 11, 2023 10:21am
176 Views
Post# 35442999

RE:RE:RE:RE:RE:RE:RE:Applying for Breakthrough seems very close now

RE:RE:RE:RE:RE:RE:RE:Applying for Breakthrough seems very close nowIt might be difficult for them to capture market share when there is such a safe, convenient and efficacious SOC treatment already in place...

enriquesuave wrote:
Rumpl3StiltSkin wrote: Exactly Gents,

TLT has had FT designation for some time now. They now have the CR %s and number of patients treated to apply for AA. BTD would be another great NR for them, should speed things up considerably. But really they don't NEED it to move towards AA, Now... If they wanted to...

I feel sorry for IBRX investors, but perhaps we may get to market before them and that would mean an even greater market potential for us.?  Time will tell 


<< Previous
Bullboard Posts
Next >>